Rosalind Franklin Institute - Next Generation Chemistry
罗莎琳德·富兰克林研究所 - 下一代化学
基本信息
- 批准号:EP/V011359/1
- 负责人:
- 金额:$ 474.38万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2020
- 资助国家:英国
- 起止时间:2020 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Life Sciences sector forms a key part of the UK economy: it employs over 220,000 people, contributes significantly to GDP and UK balance of trade, and is crucial for developing leading-edge treatments. It is underpinned by the UK's world-leading research base in the health and life sciences. Many key research breakthroughs are, in turn, enabled by advances in engineering and physical sciences (EPS) research - which provide ever more sophisticated instrumentation and methods to support the study of living organisms (from microbes to plants, animals and the human body) and biological processes (including both disease pathology and drug action). R&D across all parts of this ecosystem - from fundamental understanding to applied research to product development - is crucial for the delivery of long-term economic growth and continued advances in agriculture, food security, healthcare and public health. Historic models of innovation have often been linear, involving a degree of serendipity. Disruptive technologies and scientific breakthroughs will be accelerated if physical scientists, engineers, life scientists and industry work together, and at scale. This is the domain of the Rosalind Franklin Institute (RFI): with a focal point (Hub) at Harwell Science and Innovation Campus, linked to formal Spokes in leading HE ls across the UK, it will integrate complementary expertise from academia and industry to create a national centre of excellence for methods development at the convergence of the physical and life sciences.The diverse chemical control and editing of biological samples has profound potential well beyond current methods in traditional modes of Physical or Biological Sciences. This will ultimately complement and iteratively determine the value of other unifying goals of the Franklin such as Imaging. The ability to 'edit-characterize-and-image' could provide a grand challenge method for not only observing (imaging) biology but controlling (editing/treating) and hence understanding it in its post-translational state as a new mode of Medicine. The roadmap for Next Generation Chemistry (NGC) will unify several sub-projects that will span this spectrum of chemical control and understanding of biology.The NGC theme uses the rubric of:Construct (Synthetic Biology) -> Understand (Chemical Biology) -> Control (Chemical Medicine)In Construct, we aim to build and edit complex biological entities from the bottom-up.In Understand, we characterize and hence correlate built and modulated structures with function.In Control, we exploit this understanding to iteratively modulate and correct function with application primarily in Medicine and Biotechnology.
生命科学部门是英国经济的重要组成部分:它拥有超过220,000名员工,为GDP和英国贸易平衡做出了重大贡献,并且对开发尖端治疗至关重要。它以英国在健康和生命科学领域的世界领先研究基地为基础。许多关键的研究突破反过来又得益于工程和物理科学(EPS)研究的进步,这些研究提供了越来越复杂的仪器和方法,以支持对活生物体(从微生物到植物,动物和人体)和生物过程(包括疾病病理学和药物作用)的研究。这一生态系统的所有部分的研发-从基础知识到应用研究再到产品开发-对于实现长期经济增长以及农业、粮食安全、医疗保健和公共卫生的持续进步至关重要。历史上的创新模式往往是线性的,涉及一定程度的偶然性。如果物理科学家、工程师、生命科学家和工业界共同努力,并形成规模,颠覆性技术和科学突破将加速发展。这是罗莎琳德富兰克林研究所(RFI)的领域:在Harwell科学与创新校园有一个联络点(中心),与英国各地领先的HE LS的正式发言联系在一起,它将整合学术界和工业界的互补专业知识,创建一个国家卓越中心,在物理科学和生命科学的交汇点上开发方法。在物理或生物科学的传统模式远远超出目前的方法的深刻潜力。这将最终补充并迭代确定富兰克林的其他统一目标(如成像)的价值。“编辑-表征-和-成像”的能力可以提供一个巨大的挑战方法,不仅用于观察(成像)生物学,而且用于控制(编辑/治疗),从而将其理解为一种新的医学模式。下一代化学(NGC)的路线图将统一几个子项目,这些子项目将跨越化学控制和对生物学的理解。NGC主题使用以下标题:构建(合成生物学)->理解(化学生物学)->控制(化学医学)在构建中,我们的目标是自下而上构建和编辑复杂的生物实体。在理解中,我们表征并因此将构建和调制的结构与功能相关联。在控制中,我们利用这种理解来迭代调节和纠正功能,主要应用于医学和生物技术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benjamin Davis其他文献
A lesion-mimic mutant of Catharanthus roseus accumulates the opioid agonist, akuammicine.
长春花的损伤模拟突变体会积累阿片类激动剂 akuammicine。
- DOI:
10.1016/j.phytochem.2022.113422 - 发表时间:
2022 - 期刊:
- 影响因子:3.8
- 作者:
Fanfan Li;S. Bordeleau;K. Kim;Jonathan Turcotte;Benjamin Davis;Lan Liu;S. Bayen;V. De Luca;Mehran Dastmalchi - 通讯作者:
Mehran Dastmalchi
Enhancing User Performance by Adaptively Changing Haptic Feedback Cues in a Fitts's Law Task
通过在菲茨定律任务中自适应地改变触觉反馈线索来提高用户性能
- DOI:
10.1109/toh.2024.3358188 - 发表时间:
2024 - 期刊:
- 影响因子:2.9
- 作者:
Drake Rowland;Benjamin Davis;Taylor M. Higgins;A. M. Fey - 通讯作者:
A. M. Fey
Pediatric eosinophilic gastritis treated with benralizumab: A case report
贝那利珠单抗治疗小儿嗜酸性粒细胞性胃炎:一例报告
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
D. Cheung;Dawn Ebach;Benjamin Davis - 通讯作者:
Benjamin Davis
From the prodromal stage of multiple sclerosis to disease prevention
从多发性硬化的前驱期到疾病预防
- DOI:
10.1038/s41582-022-00686-x - 发表时间:
2022-07-15 - 期刊:
- 影响因子:33.100
- 作者:
Ruth Ann Marrie;Mark Allegretta;Lisa F. Barcellos;Bruce Bebo;Peter A. Calabresi;Jorge Correale;Benjamin Davis;Philip L. De Jager;Christiane Gasperi;Carla Greenbaum;Anne Helme;Bernhard Hemmer;Pamela Kanellis;Walter Kostich;Douglas Landsman;Christine Lebrun-Frenay;Naila Makhani;Kassandra L. Munger;Darin T. Okuda;Daniel Ontaneda;Ronald B. Postuma;Jacqueline A. Quandt;Sharon Roman;Shiv Saidha;Maria Pia Sormani;Jon Strum;Pamela Valentine;Clare Walton;Kathleen M. Zackowski;Yinshan Zhao;Helen Tremlett - 通讯作者:
Helen Tremlett
Rural Household Access to Assets and Markets: A Cross-Country Comparison
- DOI:
10.1057/ejdr.2011.15 - 发表时间:
2011-06-30 - 期刊:
- 影响因子:2.600
- 作者:
Alberto Zezza;Paul Winters;Benjamin Davis;Gero Carletto;Katia Covarrubias;Luca Tasciotti;Esteban Quiñones - 通讯作者:
Esteban Quiñones
Benjamin Davis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Benjamin Davis', 18)}}的其他基金
ISOBIOTICS: Isotopic Labeling of Biotherapeutics
ISOBIOTICS:生物治疗药物的同位素标记
- 批准号:
EP/X039501/1 - 财政年份:2023
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
Exploring and Driving Cooperative International Strategies in Sustainable Chiral Pool Natural Product Synthesis
探索和推动可持续手性库天然产物合成的国际合作策略
- 批准号:
BB/W018705/1 - 财政年份:2022
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
Radical Radiochemistry for Site- and Copy-Controlled 18F-Labeling of Proteins
用于蛋白质位点和拷贝控制 18F 标记的自由基放射化学
- 批准号:
BB/V010999/1 - 财政年份:2021
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
Understanding a Mutant that Disregulates Trehalose 6-Phosphate Action in Plants
了解破坏植物中海藻糖 6-磷酸作用的突变体
- 批准号:
BB/T016329/1 - 财政年份:2020
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
A High-throughput discovery facility for the Rosalind Franklin Institute
罗莎琳德·富兰克林研究所的高通量发现设施
- 批准号:
EP/V011367/1 - 财政年份:2020
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
Understanding and Exploiting Tunicamycin (Bio)Synthesis to Enable Novel Antibiotics and Inhibitors
了解和利用衣霉素(生物)合成来开发新型抗生素和抑制剂
- 批准号:
BB/J009725/1 - 财政年份:2012
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
Engineering stable calibration standards for biomedical research
为生物医学研究设计稳定的校准标准
- 批准号:
EP/I500200/1 - 财政年份:2011
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
The CHELL : A Bottom-Up approach to in vitro and in silico Minimal Life-like Constructs
CHELL:体外和计算机模拟最小类生命结构的自下而上方法
- 批准号:
EP/G026688/1 - 财政年份:2009
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
Creating a Synthetic Platform for Understanding and Exploiting Glycoconjugates
创建一个理解和利用糖复合物的合成平台
- 批准号:
EP/E000614/1 - 财政年份:2007
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
Dissecting the mechanism by which glycosyltransferases calalyse mannosyl transfer
剖析糖基转移酶催化甘露糖基转移的机制
- 批准号:
BB/E004350/1 - 财政年份:2007
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
相似海外基金
Open Access Block Award 2024 - The Rosalind Franklin Institute
2024 年开放获取区块奖 - 罗莎琳德·富兰克林研究所
- 批准号:
EP/Z532393/1 - 财政年份:2024
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
Open Access Block Award 2023 - The Rosalind Franklin Institute
2023 年开放获取区块奖 - 罗莎琳德·富兰克林研究所
- 批准号:
EP/Y529850/1 - 财政年份:2023
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
DTP 2022 The Rosalind Franklin Institute
DTP 2022 罗莎琳德·富兰克林研究所
- 批准号:
2741835 - 财政年份:2022
- 资助金额:
$ 474.38万 - 项目类别:
Studentship
DTP 2022 The Rosalind Franklin Institute
DTP 2022 罗莎琳德·富兰克林研究所
- 批准号:
2741926 - 财政年份:2022
- 资助金额:
$ 474.38万 - 项目类别:
Studentship
DTP 2022 The Rosalind Franklin Institute
DTP 2022 罗莎琳德·富兰克林研究所
- 批准号:
2741977 - 财政年份:2022
- 资助金额:
$ 474.38万 - 项目类别:
Studentship
Rosalind Franklin Institute Core Capital Award
罗莎琳德·富兰克林研究所核心资本奖
- 批准号:
EP/X528511/1 - 财政年份:2022
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
DTP 2022 The Rosalind Franklin Institute
DTP 2022 罗莎琳德·富兰克林研究所
- 批准号:
2741848 - 财政年份:2022
- 资助金额:
$ 474.38万 - 项目类别:
Studentship
DTP 2022 The Rosalind Franklin Institute
DTP 2022 罗莎琳德·富兰克林研究所
- 批准号:
2741956 - 财政年份:2022
- 资助金额:
$ 474.38万 - 项目类别:
Studentship
Open Access Block Award 2022 - The Rosalind Franklin Institute
2022 年开放获取区块奖 - 罗莎琳德·富兰克林研究所
- 批准号:
EP/X526927/1 - 财政年份:2022
- 资助金额:
$ 474.38万 - 项目类别:
Research Grant
DTP 2022 The Rosalind Franklin Institute
DTP 2022 罗莎琳德·富兰克林研究所
- 批准号:
2741920 - 财政年份:2022
- 资助金额:
$ 474.38万 - 项目类别:
Studentship